ospemifene (Senshio®) accepted for use within NHSScotland

Source:
Scottish Medicines Consortium - SMC
Publisher:
Scottish Medicines Consortium
Publication date:
09 September 2019

Abstract

The SMC has accepted ospemifene for treatment of moderate to severe symptomatic vulvar and vaginal atrophy (VVA) in post-menopausal women who are not candidates for local vaginal oestrogen therapy.